BIOTECH STOCKS

BridgeBio Pharma, a biotech company focused on genetic diseases, has seen a remarkable surge in its stock price, reaching an all-time high of $75. 10. Over the past year, the stock has soared by 145%, catching the attention of both Wall Street and individual investors. The company's market value sta

Biotech stocks have had a rough time since their peak in early 2021. They didn't join the market's rebound in 2022, but this summer brought a change. These stocks are tricky because most of them are in the early stages of development. They often don't have earnings or steady revenue, relying instead